Literature DB >> 33099546

ARIA 2019 Care Pathways for Allergic Rhinitis in the Kuwait Health Care System.

Mona Al-Ahmad1,2, Jasmina Nurkic3, Claus Bachert4,5, Oliver Pfaar6, Holger J Schunemann7, Wienczyslawa Czarlewski8, Anna Bedbrook9, Jean Bosquet10,11,12,13.   

Abstract

A worldwide increase in prevalence of allergic diseases has led to adaptations in national and international health care systems. ARIA (Allergic Rhinitis and Its Impact on Asthma) initiative develops internationally applicable guidelines for allergic respiratory diseases. In collaboration with international initiatives, ARIA offers updates of real-life integrated care pathways (ICPs) for digitally assisted, integrated, and individualized treatment of allergic rhinitis (AR). This article presents certain aspects of the health care system in Kuwait with reference to the management of AR and the objective of introducing ICPs and adopting the latest ARIA recommendations. Guidelines for ICPs include aspects of patients and health care providers and cover key areas of management of AR. This model of guidelines supports real-life health care better than traditional models. ARIA recommendations will be locally integrated in the health care system with the aim of improving both pharmacotherapy and allergy immunotherapy.
© 2020 The Author(s). Published by S. Karger AG, Basel.

Entities:  

Keywords:  Allergen immunotherapy; Allergic rhinitis; Integrated care pathways

Mesh:

Year:  2020        PMID: 33099546      PMCID: PMC8436665          DOI: 10.1159/000512493

Source DB:  PubMed          Journal:  Med Princ Pract        ISSN: 1011-7571            Impact factor:   1.927


  83 in total

1.  Azelastine nasal spray and desloratadine tablets in pollen-induced seasonal allergic rhinitis: a pharmacodynamic study of onset of action and efficacy.

Authors:  Friedrich Horak; Ursula Petra Zieglmayer; René Zieglmayer; Alexander Kavina; Kristina Marschall; Ullrich Munzel; Ursula Petzold
Journal:  Curr Med Res Opin       Date:  2006-01       Impact factor: 2.580

2.  BSACI guideline for the diagnosis and management of allergic and non-allergic rhinitis (Revised Edition 2017; First edition 2007).

Authors:  G K Scadding; H H Kariyawasam; G Scadding; R Mirakian; R J Buckley; T Dixon; S R Durham; S Farooque; N Jones; S Leech; S M Nasser; R Powell; G Roberts; G Rotiroti; A Simpson; H Smith; A T Clark
Journal:  Clin Exp Allergy       Date:  2017-07       Impact factor: 5.018

3.  Onset of Action of the Fixed Combination Intranasal Azelastine-Fluticasone Propionate in an Allergen Exposure Chamber.

Authors:  Jean Bousquet; Eli O Meltzer; Peter Couroux; Arkady Koltun; Ferdinand Kopietz; Ullrich Munzel; Hans Christian Kuhl; Duc Tung Nguyen; Anne Marie Salapatek; David Price
Journal:  J Allergy Clin Immunol Pract       Date:  2018-02-07

Review 4.  Pharmacotherapeutic strategies for allergic rhinitis: matching treatment to symptoms, disease progression, and associated conditions.

Authors:  Eli O Meltzer
Journal:  Allergy Asthma Proc       Date:  2013 Jul-Aug       Impact factor: 2.587

5.  Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology.

Authors:  Jean Bousquet; Peter W Hellings; Ioana Agache; Flore Amat; Isabella Annesi-Maesano; Ignacio J Ansotegui; Josep M Anto; Claus Bachert; Eric D Bateman; Anna Bedbrook; Kazi Bennoor; Mickael Bewick; Carsten Bindslev-Jensen; Sinthia Bosnic-Anticevich; Isabelle Bosse; Jan Brozek; Luisa Brussino; Giorgio W Canonica; Victoria Cardona; Thomas Casale; Alfonso M Cepeda Sarabia; Niels H Chavannes; Lorenzo Cecchi; Jaime Correia de Sousa; Elisio Costa; Alvaro A Cruz; Wienczyslawa Czarlewski; Giuseppe De Carlo; Giulia De Feo; Pascal Demoly; Philippe Devillier; Mark S Dykewicz; Yehia El-Gamal; Esben E Eller; Joao A Fonseca; Jean-François Fontaine; Wytske J Fokkens; Maria-Antonieta Guzmán; Tari Haahtela; Maddalena Illario; Juan-Carlos Ivancevich; Jocelyne Just; Igor Kaidashev; Musa Khaitov; Omer Kalayci; Thomas Keil; Ludger Klimek; Marek L Kowalski; Piotr Kuna; Violeta Kvedariene; Desiree Larenas-Linnemann; Daniel Laune; Lan T T Le; Karin Lodrup Carlsen; Olga Lourenço; Bassam Mahboub; Alpana Mair; Enrica Menditto; Branislava Milenkovic; Mario Morais-Almeida; Ralph Mösges; Joaquim Mullol; Ruth Murray; Robert Naclerio; Leyla Namazova-Baranova; Ettore Novellino; Robyn E O'Hehir; Ken Ohta; Yoshitaka Okamoto; Kimi Okubo; Gabrielle L Onorato; Susanna Palkonen; Petr Panzner; Nikos G Papadopoulos; Hae-Sim Park; Ema Paulino; Ruby Pawankar; Oliver Pfaar; Davor Plavec; Ted A Popov; Paul Potter; Emmanuel P Prokopakis; Menachem Rottem; Dermot Ryan; Johanna Salimäki; Boleslaw Samolinski; Mario Sanchez-Borges; Holger J Schunemann; Aziz Sheikh; Juan-Carlos Sisul; Rojin Rajabian-Söderlund; Talant Sooronbaev; Cristiana Stellato; Teresa To; Ana-Maria Todo-Bom; Peter-Valentin Tomazic; Sanna Toppila-Salmi; Antonio Valero; Arunas Valiulis; Erkka Valovirta; Maria-Teresa Ventura; Martin Wagenmann; De Yun Wang; Dana Wallace; Susan Waserman; Magnus Wickman; Arzu Yorgancioglu; Luo Zhang; Nanshan Zhong; Mihaela Zidarn; Torsten Zuberbier
Journal:  J Allergy Clin Immunol       Date:  2018-09-29       Impact factor: 10.793

6.  Grading local side effects of sublingual immunotherapy for respiratory allergy: speaking the same language.

Authors:  Giovanni Passalacqua; Carlos E Baena-Cagnani; Jean Bousquet; Giorgio Walter Canonica; Thomas B Casale; Linda Cox; Stephen R Durham; Desiréé Larenas-Linnemann; Dennis Ledford; Ruby Pawankar; Paul Potter; Nelson Rosario; Dana Wallace; Richard F Lockey
Journal:  J Allergy Clin Immunol       Date:  2013-05-15       Impact factor: 10.793

7.  An assessment of the onset and duration of action of olopatadine nasal spray.

Authors:  Piyush Patel; Peter S Roland; Bradley F Marple; Paul J Benninger; Harriet Margalias; Michael Brubaker; Sally F Beezley; Susan F Beezley; Margaret Drake; Susan L Potts; G Michael Wall
Journal:  Otolaryngol Head Neck Surg       Date:  2007-12       Impact factor: 3.497

8.  Electronic Clinical Decision Support System for allergic rhinitis management: MASK e-CDSS.

Authors:  Anne-Lise Courbis; Ruth Brigid Murray; Sylvie Arnavielhe; Davide Caimmi; Anna Bedbrook; Michiel Van Eerd; Govert De Vries; Gerard Dray; Ioana Agache; Mario Morais-Almeida; Claus Bachert; Karl Christian Bergmann; Sinthia Bosnic-Anticevich; Jan Brozek; Caterina Bucca; Paulo Camargos; Giorgio Walter Canonica; Warner Carr; Thomas Casale; Joao A Fonseca; Tari Haahtela; Omer Kalayci; Ludger Klimek; Piotr Kuna; Violeta Kvedariene; Desiree Larenas Linnemann; Phil Lieberman; Joaquim Mullol; Robyn Ohehir; Nikolaos Papadopoulos; David Price; Dermot Ryan; Boleslaw Samolinski; F Estelle Simons; Peter Tomazic; Massimo Triggiani; Arunas Valiulis; Erkka Valovirta; Martin Wagenmann; Magnus Wickman; Arzu Yorgancioglu; Jean Bousquet
Journal:  Clin Exp Allergy       Date:  2018-08-20       Impact factor: 5.018

9.  National clinical practice guidelines for allergen immunotherapy: An international assessment applying AGREE-II.

Authors:  D E S Larenas-Linnemann; D Antolín-Amérigo; C Parisi; A Nakonechna; J A Luna-Pech; B Wedi; I Davila; M Gómez; M Levin; J A Ortega Martell; L Klimek; N Rosario; A M Muraro; I Agache; J Bousquet; A Sheikh; O Pfaar
Journal:  Allergy       Date:  2017-10-17       Impact factor: 13.146

Review 10.  Duration of Allergen Immunotherapy for Long-Term Efficacy in Allergic Rhinoconjunctivitis.

Authors:  Martin Penagos; Aarif O Eifan; Stephen R Durham; Guy W Scadding
Journal:  Curr Treat Options Allergy       Date:  2018-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.